| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2.87 Billion | USD 6.17 Billion | 8.1% | 2024 |
FrequentlyAsked Questions
Blood group typing is a laboratory test used to determine a person's blood type based on the presence or absence of specific antigens (A, B, AB, or O) and Rh factor (positive or negative) on red blood cells. It's essential for safe blood transfusions, organ transplants, and pregnancy care.
The global blood group typing market is expected to grow due to rising blood transfusion procedures, increasing need for safe blood screening, and advancements in typing technologies.
According to a study, the global blood group typing market size was worth around USD 2.87 Billion in 2024 and is expected to reach USD 6.17 Billion by 2034.
The global blood group typing market is expected to grow at a CAGR of 8.1% during the forecast period.
North America is expected to dominate the blood group typing market over the forecast period.
Leading players in the global blood group typing market include Grifols, S.A., Immucor Inc., Ortho Clinical Diagnostics, In., Rapid Labs, Quotient, Ltd., Novacyt Group , Bio-Rad Laboratories Inc, BAG Healthcare GmbH , Day medical SA, DIAGAST, and AXO Science., among others.
The report explores crucial aspects of the blood group typing market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients